Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Joshi

Showing results (661-670 of 890) with videos related to

Pageof 89
Sort By:
International Journal of Epidemiology|May 1, 2019
Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studiesDong Hang, Amit D Joshi, Xiaosheng He, et al.
International Journal of Epidemiology|May 24, 2019
Corrigendum to: Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studiesDong Hang, Amit D Joshi, Xiaosheng He, et al.
Nature|May 6, 2026
Pollinators support the nutrition and income of vulnerable communitiesT P Timberlake, S Sapkota, N M Saville, et al.
Dalton Transactions (Cambridge, England : 2003)|January 5, 2017
Ferrocenyl helquats: unusual chiral organometallic nonlinear optical chromophoresLaura E R Buckley, Benjamin J Coe, Daniela Rusanova, et al.
Molecular Psychiatry|March 12, 2014
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter studyP M Doraiswamy, R A Sperling, K Johnson, et al.
Synapse (New York, N.Y.)|June 5, 2010
Synthesis, characterization, and monkey PET studies of [¹⁸F]MK-1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK-5435Eric D Hostetler, Waisi Eng, Aniket D Joshi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 27, 2010
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)Dean F Wong, Paul B Rosenberg, Yun Zhou, et al.
Seminars in Nuclear Medicine|June 1, 2011
Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agentJohn Lister-James, Michael J Pontecorvo, Chris Clark, et al.
British Journal of Cancer|June 17, 2022
Gallstones and risk of cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohortsXiao Luo, Wanshui Yang, Amit D Joshi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2012
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjectsAbhinay D Joshi, Michael J Pontecorvo, Chrisopher M Clark, et al.
Pageof 89

Showing results (661-670 of 890) with videos related to

Sort By:
Pageof 89
International Journal of Epidemiology|May 1, 2019
Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studiesDong Hang, Amit D Joshi, Xiaosheng He, et al.
International Journal of Epidemiology|May 24, 2019
Corrigendum to: Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studiesDong Hang, Amit D Joshi, Xiaosheng He, et al.
Nature|May 6, 2026
Pollinators support the nutrition and income of vulnerable communitiesT P Timberlake, S Sapkota, N M Saville, et al.
Dalton Transactions (Cambridge, England : 2003)|January 5, 2017
Ferrocenyl helquats: unusual chiral organometallic nonlinear optical chromophoresLaura E R Buckley, Benjamin J Coe, Daniela Rusanova, et al.
Molecular Psychiatry|March 12, 2014
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter studyP M Doraiswamy, R A Sperling, K Johnson, et al.
Synapse (New York, N.Y.)|June 5, 2010
Synthesis, characterization, and monkey PET studies of [¹⁸F]MK-1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK-5435Eric D Hostetler, Waisi Eng, Aniket D Joshi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 27, 2010
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)Dean F Wong, Paul B Rosenberg, Yun Zhou, et al.
Seminars in Nuclear Medicine|June 1, 2011
Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agentJohn Lister-James, Michael J Pontecorvo, Chris Clark, et al.
British Journal of Cancer|June 17, 2022
Gallstones and risk of cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohortsXiao Luo, Wanshui Yang, Amit D Joshi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2012
Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjectsAbhinay D Joshi, Michael J Pontecorvo, Chrisopher M Clark, et al.
Pageof 89